The recent development of sequencing technology allows identification of association between the whole spectrum of genetic variants and complex diseases. Over the past few years, a number of association tests for rare variants have been developed. Jointly testing for association between genetic variants and multiple correlated phenotypes may increase the power to detect causal genes in family-based studies, but familial correlation needs to be appropriately handled to avoid an inflated type I error rate. Here we propose a novel approach, for multivariate family data using kernel machine regression (denoted as MF-KM), which is based on linear mixed model framework and can be applied to a large range of studies with different types of traits. In our simulation studies, the usual kernel machine test has inflated type I error rates when directly applied to familial data, while our proposed MF-KM method preserves the expected type I error rates. Moreover, the MF-KM method has increased power compared to methods that either analyze each phenotype separately while considering family structure or use only unrelated founders from the families. Finally, we illustrate our proposed methodology by analyzing wholegenome genotyping data from a lung function study.
INTRODUCTION
Genome-wide association studies (GWASs) have been widely used to identify common single nucleotide polymorphisms (SNPs) associated with complex human diseases (HUNTER et al. 2007 ; WELLCOME TRUST CASE CONTROL 2007; YEAGER et al. 2007; MANOLIO et al. 2008; HINDORFF et al. 2009 ). In a typical GWAS, large numbers SNPs are genotyped on hundreds or thousands of subjects, and each SNP is subsequently tested, one by one, for association with the phenotype of interest. However, this traditional single-marker association test is not powerful to detect rare variants that confer susceptibility to complex diseases (LI and LEAL 2008; SCHORK et al. 2009 ). With the recent development of sequencing technology, identification of rare susceptibility variants for complex diseases has become feasible, provided that novel statistical methods are developed to obtain optimal results.
To increase the power to detect association using rare susceptibility variants, many set-based statistics have been developed which evaluate the joint effect of a group of rare genetic variants in a predefined genomic region on the phenotype of interest (MORGENTHALER and THILLY 2007; LI and LEAL 2008; LI and LEAL 2009; MADSEN and BROWNING 2009; HAN and PAN 2010; MORRIS and ZEGGINI 2010; PRICE et al. 2010; LIN et al. 2011; LIN et al. 2012; LIN et al. 2013; LIN et al. 2014) . One commonly used method is the sequence kernel-machine-based association test (SKAT) (WU et al. 2010; WU et al. 2011; YAN et al. 2014; YAN et al. 2015) . SKAT is a powerful, flexible, and computationally efficient approach for set-based association testing. To increase power, this kernel machine (KM) method assigns weights to each marker and uses the weighted summation to construct test statistics. In addition, SKAT can easily include non-genetic covariates. Both linear and nonlinear kernels may be used to test the genotype-phenotype relationship. Furthermore, SKAT's test statistic follows a known mixture of chi-square distributions. Thus, p-values can be quickly computed analytically without performing resampling.
In genetic studies of complex diseases, multiple correlated phenotypes are often collected.
Jointly testing the association between these correlated phenotypes and genetic variants may increase statistical power to detect causal genes underlying complex diseases. Several multivariate approaches developed for this purpose (VERZILLI et al. 2005; ZAPALA and SCHORK 2006; LIU et al. 2009; ZHANG et al. 2010a; MAITY et al. 2012) have demonstrated improved statistical power to detect susceptibility variants, especially for pleiotropic variants that influence multiple phenotypes (ZHU and ZHANG 2009; SIVAKUMARAN et al. 2011) .
Family-based designs have been widely used in association studies of complex traits (FALK and RUBINSTEIN 1987; OTT 1989; TERWILLIGER and OTT 1992; SPIELMAN et al. 1993) . Although GWASs with unrelated samples often employ general linear models for quantitative phenotypes, this approach can lead to inflated type I error rates in family-based studies if familial correlation is ignored. In family-based studies, a linear mixed model including a random covariate with polygenic effects can account for familial correlations, and is thus preferable over a general linear model. In family-based studies, the covariance of random polygenic effects between all subjects is proportional to their kinship coefficients. Linear mixed models with a kinship matrix have been commonly applied in family-based GWASs (ALMASY and BLANGERO 1998; RABINOWITZ and LAIRD 2000; YU et al. 2006; KANG et al. 2010; ZHANG et al. 2010b ). More recently, SKAT has been extended to test for quantitative phenotypes in family-based samples by including a kinship matrix (SCHIFANO et al. 2012a; CHEN et al. 2013; OUALKACHA et al. 2013 ).
Here, we develop a new test for gene-based association between rare variants and multiple correlated phenotypes for family-based samples. The recently published MFQLS statistic (WON et al. 2015 ) is for family-based multivariate association analysis with multiple variants, but it is specifically for common variants. Our proposed method, which uses kernel machine regression and is denoted as MF-KM (for multivariate family data -kernel machine), is based on linear mixed model framework and can be applied to a large range of studies with different types of traits, such as longitudinal studies. In our simulation studies, we show that a usual kernel machine test (MAITY et al. 2012 ) (M-KM, considering the correlation between multiple phenotypes) has inflated type I error rates when directly applied to familial data. In contrast, our MF-KM method preserves the expected type I error rates when employed in family-based samples. Moreover, the MF-KM method has increased power compared to methods that either analyze each phenotype separately (F-KM, which considers family structure) or use only unrelated founders (M-KM-ind). Finally, we illustrate our proposed methodology by analyzing whole-genome genotyping data from a lung function study.
METHODS

Kernel Machine Regression in a Linear Mixed Model Framework
For kernel machine (KM) regression in a linear mixed model framework on a data set containing n people, we assume that the n × 1 vector of the quantitative trait y follows a linear mixed model:
where X is an n × p covariate matrix, β is a p × 1 parameter vector for fixed effects (an intercept and p -1 covariates), G is an n × q genotype matrix for q genetic markers in the region of interest, γ is a q × 1 vector for the random effects of genetic markers, u is n × 1 vector for the random effects of any correlation (e.g., multiple phenotypes or familial structure), and ε is an n × 1 vector for the random error. The random effect γ is assumed to follow a normal distribution with mean zero and variance τW, so the null hypothesis we are interested in testing is H 0 : γ=0, which is equivalent to testing H 0 : τ=0. A variance component score test known as the locally most powerful test can be used to test this H 0 (WU et al. 2011) . The error ε and the random effects u are also assumed to follow normal distributions and are uncorrelated with each other and with γ. To be specific, we assume that
where W is a q × q diagonal matrix with predefined weights for each variant [such as
, K is a n × n covariance matrix, and 2 is the error variance component.
Under the above assumptions, the variance of the quantitative phenotype y can be described as
Under the null hypothesis, the estimates are
Following the same rationale as in previous derivations of the score statistic (ZHANG and LIN 2003; LIU et al. 2007; KWEE et al. 2008) , we have the test statistic
where ̂ is the vector of estimated fixed effect coefficients of covariates under H 0 , and ̂ is the estimated covariance matrix of y under H 0 . The statistic is a quadratic form of ( −̂) and follows a mixture of chi-square distributions although some of the parameters are estimated (YUAN and BENTLER 2010; SCHIFANO et al. 2012b ) under H0. Thus, the p-values can be calculated using different algorithms such as the moment-matching methods, (Satterthwaite 1946; Liu et al. 2007 ), the Davies exact method (Davies 1980) , or Kuonen's saddlepoint method (Kuonen 1999) . In this work, we chose to use the Davies method.
Kernel Machine for Quantitative Traits in Multivariate Family Data (MF-KM)
The statistic derived in Equation 1 above can be extended to handle quantitative traits in multivariate family data, denoted as MF-KM (which stands for multivariate family kernel machine). Here, the null hypothesis is that the group of genetic variants is not associated with any traits. For simplicity of illustration, we consider a data set containing m individuals and two correlated phenotypes. Under the null hypothesis, H 0 : τ=0, the model with correlation among phenotypes and familial structure is
where y is a vector of quantitative trait (i.e., y = (y 11 , y 12 , y 21 , y 22 , …, y m1 , y m2 ) where m is the number of individuals). is the fixed effects of covariates, h is the random effect of correlated phenotypes corresponding to the polygenic contribution, and is the random effect of correlated phenotypes corresponding to the random environmental contribution. In our notation, we do not explicitly distinguish families which can be handled implicitly by the kinship matrix in the variance of h. Since we consider two correlated phenotypes (BAUMAN et al. 2005) , 2 ) = where is twice the m × m kinship matrix obtained either from familial relationship or genomewide data and ⨂ is the kronecker product. 1 2 , 2 2 , 12 , 1 2 , 2 2 and 12 represent the polygenic variances of the first and second phenotypes, the polygenic covariance between the two phenotypes, the environmental variances of the first and second phenotypes, and the environmental covariance between the two phenotypes, which can be estimated from the data, by using the classic optimization methods such as Nelder-Mead method (NELDER and MEAD 1965) or quasi-Newton method (BROYDEN 1969; FLETCHER 1970; GOLDFARB 1970; SHANNO 1970) , and then the test statistic can be constructed.
Simulation Study
Simulation of sample genotypes: We simulated sample genotypes based on a pool of 10,000
haplotypes over a 200 kb chromosome from a calibrated coalescent model (SCHAFFNER et al. 2005 ) with linkage disequilibrium (LD) structure mimicking the European ancestry.
We simulated family data using two different family structures (Figure 1) . First, we simulated 300 trio families with father, mother and one child ( Figure 1A ) by first randomly selecting 1,200 haplotypes as the parents' haplotypes. The offspring haplotypes were generated by randomly transmitting one of the two haplotypes of the father and the mother to the child.
Similarly, we simulated 100 three-generation families with two grandparents, two independent parents who marry into the families, two dependent parents as the offspring of grandparents, and four children ( Figure 1B ) by randomly picking two haplotypes for each founder, and then randomly picking haplotypes to be transmitted to their descendants. Then, we randomly selected 30 rare variants (MAF<0.05) from the simulated family data over the 200kb region as one genotype dataset. We generated 100 such genotype datasets in the analysis for each of the two family structures.
Type I error rate: To measure type I error rates, for each of the 100 genotype datasets, we simulated 100 sets of a two-dimensional null phenotype independently of the genotypes. For each trio family, the vector of six quantitative phenotypes for family i were generated via the model:
where 1 is a continuous covariate generated from a normal distribution with mean 50 and standard deviation 5, which repeats twice to mimic two phenotypes for each individual. In other words, one single value is drawn from the distribution for one individual and this value is assigned to both of the individual's phenotype vectors. 2 is a dichotomous covariate generated from a Bernoulli distribution with probability 0.5, which is also repeated twice for two where 1 2 , 2 2 , 1 2 and 2 2 were set to 1, the covariance 12 and 12 were set to 0.8. The phenotypes for all the subjects were generated in the same way and the 100 sets of simulated phenotypes for each of the 100 genotype data sets were used to evaluate the type I error rates. In the scenario of families with three generations, the phenotypes were generated in an analogous way, but the kinship matrix ( ) was more complicated. Both the fixed effect parameters and variance parameters were assumed unknown when analyzing the simulated data, and they can be estimated from the simulated data.
When analyzing the family data, we compared the performance of multivariate family KM (MF-KM) to four other approaches: (1) family KM ignoring the correlation between traits (F-KM) applied to the first and second phenotypes separately, (2) multivariate KM without considering familial structure (M-KM), (3) M-KM using independent founders (M-KM-ind), and (4) Fisher's method (FISHER 1950) combining the p-values of F-KM applied to the first and second phenotypes treating the two phenotypes as independent (Fisher-F-KM).
Power evaluation: To evaluate power, we used the same genotypes as described above, but let the phenotypes be associated with the genotypes. We compared MF-KM with F-KM and M-KMind. The quantitative phenotypes for one family were generated via the model:
= 0.05 1 + 0.5 2 + 1 1 + 2 2 + ⋯ + + where 1 and 2 were the same as described above, 1 , 2 , … , were the genotypes of causal SNPs, and 1 , 2 , … , were effect sizes of the causal SNPs. We considered that 30% and 20% of all variants were disease susceptibility variants, and that was determined the same as for the evaluation of type I error rates. Furthermore, 1 , 2 , … , were set to | 10 | in order to assign large weights to rare variants, where = 0.4 was chosen such that when MAF = 0.0001, = 1.6 (WU et al. 2011) . Because the kernel machine regression could handle both risk and protective variants, we also considered that 1/3 of the causal variants were protective, which meant = − | 10 | (i.e., 20% disease variants and 10% protective variants; and 13% disease variants and 7% protective variants). The phenotypes for all families were generated in the same manner, and these 100 sets of phenotypes for each of the 100 genotype data sets in each family scenario were used to evaluate the power. 
RESULTS
Simulation of the Type I Error Rate
Statistical Power Comparison
Because M-KM and Fisher-F-KM have inflated type I error rates for related samples, we only investigated the power of MF-KM, F-KM and M-KM-ind. As shown in Figure 3 , the power of MF-KM is consistently higher than that of F-KM (which uses only one phenotype) and M-KM-ind. This is expected because MF-KM makes full use of the data, while in contrast, F-KM uses only one phenotype at a time and M-KM uses unrelated founders in order to preserve correct type I error rates. In the simulation studies, the covariance 12 and 12 between two phenotypes were set to 0.8. In addition, we varied 12 and 12 so as to study the effect of the correlation between phenotypes on the power. As shown in Figure 1S , the results show that MF-KM assuming equal genetic effects on both phenotypes performs the best when the correlations between phenotypes are low to moderate, and phenotypes have the same direction of genetic effects and have similar effect size; MF-KM assuming non-equal genetic effects on both phenotypes performs the best when the correlations between phenotypes are moderate to high, and phenotypes have the different effect size and/or have different direction of effects.
Analysis of Genome Wide Lung Function Data
To evaluate the performance of our statistic on a real data set, we applied the method to data from a lung function study (CHEN et al. 2014; CHEN et al. 2015) to carry out gene-based genome wide association tests of the correlated lung function phenotypes FEV 1 (Forced Expiratory Volume in One Second) and FEV 1 /FVC (Forced Vital Capacity) ratio. The data contain 578
Costa Rican subjects with and without COPD (Chronic Obstructive Pulmonary Disease), including 316 samples from 13 families, with 464 subjects being genotyped. The 72 subjects with unconfirmed COPD status were excluded. The detailed recruitment criteria are described elsewhere (CHEN et al. 2014) . A genome-wide panel of 658,502 SNPs was genotyped, including 591,381 common variants (MAF≥0.05) and 67,121 rare variants (MAF<0.05). We assigned rare variants to a gene if they were located within a 5kb flank of the gene on either side. In the end, 7,064 genes were used in the analysis. We analyzed the association between the correlated twodimensional FEV 1 & FEV 1 /FVC phenotypes and each of the 7,064 genes comprised of rare variants using MF-KM adjusting for age, gender, height, and COPD status. The COPD status included as a covariate to control for potential ascertainment effects, because the samples were recruited according to COPD status. In our dataset, the Pearson correlation between FEV 1 and FEV 1 /FVC is 0.57. In the final analysis, 398 genotyped subjects with full phenotypes were used, but there are still missing genotypes. To handle these, we assigned them to the homozygous reference genotype. In this test, we assumed that the phenotype is caused by rare genetic variants, and thus Wu's weight (WU et al. 2011 ) was applied to give rarer variants larger effect sizes. The Manhattan plots of p-values for genes from MF-KM and F-KM are shown in Figure   4 . In this plot, the location of each gene is determined by the location of its first marker. Using the MF-KM statistic, two genes, COL6A6 and RBM16 (marginally), were found to be significantly associated with the joint phenotype of FEV 1 and FEV 1 /FVC at an α level of 7×10 -6
(which is the Bonferroni corrected significance level). Using F-KM, these two genes were also found associated with FEV 1 alone. COL6A6 includes 7 rare variants out of 31 genetic variants and RBM16 includes 2 rare variants out of 29 genetic variants. The rare alleles in both COL6A6
and RBM16 seem to be associated with higher risk for lung function, because more individuals with higher proportion of rare alleles are in the low FEV 1 & FEV 1 /FVC area (the black area in Figure 5 ) than in the high FEV 1 & FEV 1 /FVC area (the red area in Figure 5 ). Moreover, (chr3: 130,274,178 -130,400,888) is in the chronic obstructive pulmonary disease related regions based on Rat Genome Database (RGD) (SHIMOYAMA et al. 2015) . There are two known chronic obstructive pulmonary disease related regions, COPD14_H (chr3: 36, 484, 785, 038) and COPD16_H (chr3: 49, 418, 022, 430) .
COL6A6
DISCUSSION
Family-based study designs have been widely used in investigating complex diseases, and hundreds of thousands of genetic variants, both common and rare, have been genotyped with advances in high-throughput sequencing technology. Thus, appropriate statistical methods are needed for analyzing data from these studies, while accounting for potential pleiotropic effects.
Therefore, here we developed the MF-KM statistic using a linear mixed model framework to analyze multivariate data with quantitative traits in family-based studies.
MF-KM shares the advantages of other set-based methods, such as improved power and reduced multiple testing by jointly testing a set of genetic variants. Our simulation studies show that MF-KM preserves the desired type I error rates. When multiple phenotypes are available, we
show that MF-KM achieves higher power than commonly used alternate methods. Based on our simulation results, we believe that MF-KM provides a good option for genetic analysis of multivariate data in family-based studies.
The computational time required to implement the MF-KM depends on sample size, the number of genetic variants, and the complexity of the model being tested under the null hypothesis. In fact, the computational time of fitting a model under the null hypothesis may not be critical when performing a genome wide study. Because MF-KM is a score test, the estimates of fixed effects coefficients and the covariance matrix under the null hypothesis are independent of the genetic variants. Therefore, the linear mixed model under the null hypothesis only needs to be fitted once. The ̂ and ̂ can then be saved and reused to construct test statistics for all the genes. Therefore, the total computational time is greatly reduced. On the other hand, processing genes takes most of the computational time. If the number of markers in a gene is large, inverting the large matrix is still computationally intensive. One way to handle this would be to further group their variants into subgroups such as common, rare non-synonymous or synonymous coding variants as in our previous work , and to also use LD blocks if the subgroups are still large; in addition, we may use fast algorithms proposed for linear mixed models, such as EMMA/EMMAX (KANG et al. 2010; ZHANG et al. 2010b ), TASSEL (ZHANG et al. 2010b ) and others (LIPPERT et al. 2011; SVISHCHEVA et al. 2012; ZHOU and STEPHENS 2012; ZHOU and STEPHENS 2014) (BALDING and NICHOLS 1995; LYNCH and RITLAND 1999; RITLAND 2005; YU et al. 2006; KANG et al. 2010; LIU et al. 2011) . Using the estimated kinship coefficients allows us to handle any relationship, known or unknown, in the samples. In behavioral and psychological studies, familial correlation is not only influenced by genetics but also shared environment that needs to be considered in addition to kinship coefficients (MCGUE and BOUCHARD 1998; TURKHEIMER and WALDRON 2000; HALLMAYER et al. 2011) . In the presence of shared environment, our proposed test statistic could yield inflated type I errors and this could be controlled by including an extra random intercept within families in the null model, but model complexity increases accordingly. In our lung function study, the shared environmental influence is not assumed.
Although we have only studied the performance of a linear kernel here, it would be straightforward to use a non-linear kernel within the flexible kernel machine-regression framework when a non-linear association between a disease and genetic variants is assumed. 
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